QuantuMDx develops QC analytics system for cell & gene therapies

QuantuMDx Group Ltd has announced plans to expand the potential of its Q-POC™ technology and develop a quality control analytics system for cell and gene therapies (C&GTs), to be evaluated

Share
QuantuMDx and Molbio announce Memorandum of Understanding (MoU)

  QuantuMDx Group Limited and Molbio Diagnostics Private Limited have signed a memorandum of understanding (MoU) to explore opportunities for joint working in infectious disease diagnostics, with an initial focus

Share